Key statistics
On Friday, Biontech SE (0A3M:LSE) closed at 109.50, -16.63% below its 52-week high of 131.34, set on Sep 17, 2024.
52-week range
Open | 111.50 |
---|---|
High | 109.50 |
Low | 109.50 |
Bid | 107.00 |
Offer | 112.00 |
Previous close | 111.50 |
Average volume | 32.99k |
---|---|
Shares outstanding | 240.39m |
Free float | 214.95m |
P/E (TTM) | -- |
Market cap | 26.69bn USD |
EPS (TTM) | -3.69 USD |
Data delayed at least 15 minutes, as of Jul 18 2025 15:15 BST.
More ▼
- BioNTech gibt den Rücktritt von Ryan Richardson aus dem Vorstand bekannt
- BioNTech Announces Ryan Richardson to Step Down from the Management Board
- EQS-News: GENUI sells labor team to Galenica
- EQS-News: Mallia Innovations: Mallia Appoints Jens Holstein, Dr. Alexandra Ogilvie, and Dr. Ulrich Dauer to its Advisory Board
- EQS-News: MIG Capital Announces €50 Million in Series A Funding for Look Up
- BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an
- BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
- EQS-News: Mallia sets strategic course for future and completes €5.5 million financing
- BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
- BioNTech und Bristol Myers Squibb geben globale strategische Partnerschaft zur gemeinsamen Entwicklung und Kommerzialisierung des bispezifischen Antikörperkandidaten BNT327 in einer Vielzahl solider Tumorarten bekannt
More ▼